home Categoría general, Diseño Industrial, Plástico Polycarbonate safety for baby bottles

Polycarbonate safety for baby bottles

 Bisphenol is o­ne of the raw materials to produce polycarbonate, the most common used polymer in the packaging manufacture  for baby bottles and big bottles for purified water.

EFSA’s AFC Panel has issued a further scientific opinion o­n a specific aspect of the chemical bisphenol A (BPA). The Panel concluded that after exposure to BPA, the human body rapidly metabolises and eliminates the substance.
 
The European Food Safety Authority’s AFC Panel has issued a further scientific opinion o­n a specific aspect of the chemical bisphenol A (BPA), concerning its elimination from the body and how that relates to the risk assessment of BPA for humans. The aim was to take into account recent data and consider any implications for the existing EFSA advice o­n BPA set out in its 2006 opinion, which concluded that exposure to BPA is well below the Tolerable Daily Intake (TDI). People are exposed to BPA which may be present in food through its use in certain food contact materials such as baby bottles and cans.

1151b1
 
The conclusions of the Panel are that after exposure to BPA the human body rapidly metabolises and eliminates the substance. This represents an important metabolic difference compared with rats. EFSA will continue to monitor closely scientific findings regarding BPA and any related health effects.
 
The AFC Panel, in its final session, took into account both the previous and the most recent information and data available o­n the way that BPA and related substances are handled in the human body. The Panel concluded that the exposure of the human foetus to BPA would be negligible because the mother rapidly metabolises and eliminates BPA from her body. The scientists also concluded that newborns are similarly able to metabolise and eliminate BPA at doses below 1 milligram per kilogram of body weight per day. This implies that newborns could effectively clear BPA at levels far in excess of the TDI of 0.05 mg/kg bw set by the Panel and therefore its 2006 risk assessment remains valid.
 
In its previous risk assessment, the Panel derived a TDI of 0.05 mg/kg body weight based o­n the no-observed-adverse-effect level (NOAEL) of 5 milligram/kg body weight/day for effects in rats and included an uncertainty factor of 100. In this latest assessment, the Panel concluded that this TDI provides a sufficient margin of safety for the protection of the consumer, including foetuses and newborns.
 
EFSA took note of the U.S. National Toxicology Program’s draft brief o­n BPA and of the Canadian government’s recent Draft Screening Assessment o­n BPA, which took into account findings from the low-dose studies, notably with respect to neurodevelopmental toxicity, though both pointed out that these studies were limited in rigour, consistency and biological plausibility.
 
EFSA also took into account the recent report published by o­ne of the institutes of the European Commission’s Joint Research Centre (EC, 2008) which concluded that due to the low confidence in the reliability of the developmental neurotoxicity studies and the lack of consistency in the results of behavioural testing, no conclusions can be drawn from these studies. This opinion is very similar to that of EFSA in 2006.
 
 
Press release by EFSA
 
See also:
http://www.efsa.europa.eu 
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902017492.htm
http://www.bisphenol-a.org